TNFRSF1B and neoplasm: Although the treatment with TNFR2-PLGA-ADR markedly reduced TNFR2-expressing tumor-infiltrating Tregs, TNFR2 expression and proportion of Tregs in the spleen were not inhibited (data not shown).